Orion Minerals (ORN) Investor Update summary
Event summary combining transcript, slides, and related documents.
Investor Update summary
15 May, 2026Scientific and operational milestones
Achieved 60% GLA expression in safflower seeds, surpassing expectations and improving oil yield.
Received USDA APHIS regulatory clearance for GLA-producing safflower, completing the U.S. regulatory pathway.
Scaled up prototyping operations from 3L to 300L, confirming transgenic events in seeds.
Advanced soybean and pea projects to key development stages, confirming gene integration and expression.
Expanded safflower seed multiplication by 42x for SPC2 and 25x for GLASO.
Integration and business development
Acquired a fully operational soybean processing facility with 10,000 tons/year capacity.
Signed MOU with Bioceres Crop Solutions for up to 20,000 tons of HB4 soybeans over three years.
HB4 soybeans offer drought tolerance, traceability, and lower environmental footprint.
Integration of upstream and downstream capabilities to support TVP production.
Market opportunity and business plan
Total addressable market for 2025 estimated at $827 billion, with a $37 billion serviceable market.
Business plan includes four stages, progressing from traditional soy TVP to molecular farming-based ingredients.
Asset-light approach with a global network of customers and sustainable procurement.
Latest events from Orion Minerals
- $15.4M raised and Glencore financing advances, paving way for PCZM construction and 2027 output.ORN
Q4 2026 TU - Shareholders strongly backed all resolutions on capital raising, acquisitions, and incentives.ORN
AGM 2026 - Secured US$250M Glencore funding, completed OCP acquisition, and advanced toward 2027 production.ORN
Q3 2026 TU - Advancing PCZM and Okiep projects with strong economics and strategic funding for 2027 production.ORN
Investor presentation - DFS confirms strong economics; major financing secured; first production targeted for 2026.ORN
H2 2025 - Advanced mine development, narrowed losses, and secured funding for 2025 production targets.ORN
H2 2024 - Glencore financing close, project execution advances, and first PCZM concentrate targeted for late 2026.ORN
Q2 2026 TU - Half-year net loss narrowed to $6.42M as major project funding and execution advanced.ORN
H1 2026 - All resolutions passed with strong support, and major capital raising and financing plans were highlighted.ORN
AGM 2025